Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 11.3% – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price shot up 11.3% on Monday. The company traded as high as $3.60 and last traded at $3.7390. Approximately 11,364 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 76,952 shares. The stock had previously closed at $3.36.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, Anbio Biotechnology currently has an average rating of “Hold”.

Anbio Biotechnology Trading Up 8.2%

The company has a 50 day moving average of $5.47 and a two-hundred day moving average of $16.73.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.